Rocket Pharmaceuticals

Yahoo Finance • 3 months ago

Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors

CRANBURY, N.J., September 10, 2024--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet... Full story

Yahoo Finance • 10 months ago

15 Best Strong Buy Stocks To Invest In

In this piece, we will take a look at the 15 best strong buy stocks to invest in. If you want to skip our overview of analyst ratings and the finance industry, then you can take a look at the 5 Best Strong Buy Stocks To Invest In. The fin... Full story

Yahoo Finance • last year

11 Most Promising Biotech Stocks to Buy According to Analysts

In this article, we will take a look at the 11 most promising biotech stocks to buy according to analysts. To skip our analysis of the recent trends, and market activity, you can go directly to see the 5 Most Promising Biotech Stocks to Bu... Full story

Yahoo Finance • last year

Billionaire Lee Ainslie’s Top 10 Stock Picks

In this article, we will take a look at Billionaire Lee Ainslie's top 10 stock picks. For moreAinslie's stocks, head on over to Billionaire Lee Ainslie's Top 5 Stock Picks. Hedge fund managers are known for investing in various asset clas... Full story

Yahoo Finance • last year

With This Rally, Rocket Just Might Take Off

Let me tell you why I and how I added this biotech name, and look at the bigger picture of the market and economy. Despite good news on a myriad of fronts, the stock was clearly swimming upstream as the biotech sector sold off hard over th... Full story

Yahoo Finance • last year

Should You Hold Rocket Pharmaceuticals (RCKT)?

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. The fund declined 6.05% (Institutional Shares) in the quarter compared to a... Full story

Yahoo Finance • 2 years ago

Here’s Why Rocket Pharmaceuticals (RCKT) Stock Suffered in Q1

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. The first quarter was difficult for the fund, as it failed to participate i... Full story

Yahoo Finance • 2 years ago

Rocket Pharmaceuticals Announces Leadership Expansion to Support Company on Evolution Towards Commercial Stage

Jonathan Schwartz, M.D., appointed Chief Gene Therapy Officer to enhance the Company’s focus on strategic application of gene therapy technologies to current and future therapeutic areas Mark White, MB.ChB, named Chief Medical Officer; Dr... Full story

Yahoo Finance • 2 years ago

Rocket Pharmaceuticals to Participate in the 43rd Annual Cowen Health Care Conference

CRANBURY, N.J., March 01, 2023--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders with high unm... Full story

Yahoo Finance • 2 years ago

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial and Operational Results

Advanced pipeline of four clinical programs across AAV cardiology and LV hematology portfolios delivering strong results for Danon Disease, Fanconi Anemia, LAD-I and PKD Expanded leadership position in AAV cardiac gene therapy, with signi... Full story

Yahoo Finance • 2 years ago

Rocket Pharmaceuticals Provides Update on Anticipated Registration Path for RP-A501 in Danon Disease Following End-of-Phase 1 FDA Meeting

Based on ongoing FDA discussion, Rocket to pursue a biomarker-basedcomposite endpoint for a single arm, open-label pivotal trial with a natural history comparator Initiation of initial component of global study anticipated in 1H’23 CRANB... Full story

Yahoo Finance • 2 years ago

TipRanks ‘Perfect 10’ List: 3 Top-Rated Stocks That Could Shine in 2023

As we head into the final stretch of 2022, with less than three weeks until we turn the page to 2023, the markets and the economy are sending a series of mixed signals. Stocks have leveled out somewhat over the past month, with reduced vol... Full story

Yahoo Finance • 2 years ago

EQUITY ALERT: The M&A Class Action Firm Reminds Investor of Its Investigation of the Merger – HVBC, PFHD, RCKT, LBC

NEW YORK, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Sec... Full story

Yahoo Finance • 2 years ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SBCF, RCKT, RCOR, SLDB

NEW YORK, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 years ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MTCR, SBET, RCKT, RCOR

NEW YORK, Nov. 13, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 years ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCKT, RCOR, TALO

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 years ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCKT, SBET, OCSL, STOR

NEW YORK, Oct. 23, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 years ago

15 Small Company Stocks You Should Own Now for the Next Decade

In this article, we discuss 15 small company stocks you should own now for the next decade. If you want to read about some more stocks, go directly to 5 Small Company Stocks You Should Own Now for the Next Decade. Small company stocks wer... Full story

Yahoo Finance • 3 years ago

We Think Rocket Pharmaceuticals (NASDAQ:RCKT) Can Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd... Full story